You are here

Home

Clinical Trials: Neuromuscular Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Friday, October 1, 2021 - 12:00
MABs Therapy m.3243A>G Mutation Carriers
Condition:   Mitochondrial Myopathies
Intervention:   Biological: autologous mesoangioblasts
Sponsor:   Maastricht University
Recruiting
Posted: Thursday, September 2, 2021 - 12:00
Cell Therapy for IBM by Muscle Injection of ADSVF: a Phase I Trial
Condition:   Inclusion Body Myositis
Intervention:   Biological: ADSVF
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting
Posted: Friday, August 13, 2021 - 12:00
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intrathecal Injection for ALS
Condition:   Amyotrophic Lateral Sclerosis
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Recruiting
Posted: Monday, July 26, 2021 - 12:00
Evaluate the Safety, Tolerability and Efficacy of PN-101 in Patients With Refractory Polymyositis or Dermatomyositis
Conditions:   Polymyositis;   Dermatomyositis
Intervention:   Biological: PN-101
Sponsor:   Paean Biotechnology Inc.
Not yet recruiting
Posted: Friday, July 23, 2021 - 12:00
Inclusion Body Myositis Treatment With Celution Processed Adipose Derived Regenerative Cells
Condition:   Inclusion Body Myositis
Intervention:   Device: Adipose Derived Regenerative Cells
Sponsor:   University of Kansas Medical Center
Not yet recruiting
Posted: Tuesday, June 8, 2021 - 12:00
Search for Diagnostic and Prognostic Biomarkers in Systemic Sclerosis and Inflammatory Myopathies
Conditions:   Systemic Sclerosis;   Inflammatory Myopathies
Intervention:   Other: Collection of biological samples
Sponsor:   University Hospital, Strasbourg, France
Not yet recruiting
Posted: Monday, April 19, 2021 - 12:00
Clinical Trial on the Use of Cell Therapy in the Treatment of Patients With Amyotrophic Lateral Sclerosis
Condition:   ALS (Amyotrophic Lateral Sclerosis)
Interventions:   Drug: MNC (Mononuclear cells);   Drug: Placebo / Saline
Sponsor:   Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Not yet recruiting
Posted: Tuesday, February 9, 2021 - 12:00
Evaluatiton the Efficacy and Safety of Mutiple Lenzumestrocel (Neuronata-R® Inj.) Treatment in Patients With ALS
Condition:   Amyotrophic Lateral Sclerosis
Interventions:   Biological: Lenzumestrocel;   Drug: Riluzole
Sponsor:   Corestem, Inc.
Recruiting
Posted: Monday, January 25, 2021 - 12:00
Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)
Conditions:   Polymyositis;   Dermatomyositis
Intervention:   Drug: MESENCHYMAL STROMAL CELLS (MSC's)
Sponsor:   University of Florida
Not yet recruiting
Posted: Friday, December 4, 2020 - 12:00
Human Amniotic Membrane and Mesenchymal Stem Cells Composite
Condition:   Brachial Plexus Neuropathies
Interventions:   Procedure: Nerve transfer procedure;   Procedure: Nerve transfer with HAM-AdMSC composite wrapping
Sponsor:   Dr. Soetomo General Hospital
Recruiting

Pages